PPARG and urinary bladder carcinoma: The goal of this study was to determine if the activation of PPARγ and inhibition of cell proliferation in the UROtsa parent and the As3+-transformed UROtsa isolates would repress the expression of genes involved in maintaining the basal/squamous type of bladder cancer and induce genes that were associated with the luminal/differentiated state of bladder cancer.